- Location
1
result for "
cancer treatment drug
"-
Ziopharm Oncology's Palifosfamide (ZIO-201) Recieves Patent No. 8,232,262 From USPTO
Aug 3, 2012The US Patent and Trademark Office (USPTO) has granted patent No. 8,232,262 to Ziopharm Oncology's palifosfamide (ZIO-201). The patent covers palifosfamide compositions, formulations, methods of use and methods of manufacture, which now ...
Tags: USPTO, patent, Palifosfamide, cancer treatment drug
